De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma

To join this study, you need to have a confirmed diagnosis of oropharyngeal cancer that's linked to the HPV virus. Your cancer should be at an early stage (T1-3 N0-1 M0), and you must be considered suitable for either radiation alone or radiation combined with other treatments.

You also need to be at least 18 years old and generally well enough to take part. This is checked using a specific health score called an ECOG performance status (this score should be 0, 1, or 2). You should be able to speak either English or French well enough to fill out questionnaires about your quality of life.

Before joining, you'll need to give your permission by signing a consent form. If you're a woman who could have children, or a man who could father children, you'll need to agree to use effective contraception during the study. You’ll also need to have some specific scans of your head, neck, and body done within 8 weeks before starting treatment, and be willing to provide tissue and blood samples for further tests.

If you decide to join this study, you'll be giving permission for researchers to look more closely at your cancer tissue and blood samples. This helps them understand more about your cancer and how treatments work. You'll also need to fill out questionnaires about your health and how you're feeling, both in English or French.

The actual treatment you receive will involve radiation, but the study is designed to see if a slightly different, potentially reduced, radiation approach works as well as the standard treatment. The total length of your participation, including follow-up appointments, will depend on your treatment plan and the specific monitoring schedule. The study aims to get you started with treatment within three weeks of signing up, and you'll need to be available for regular check-ups to make sure the treatment is working and to monitor any side effects.